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The nervous system is essential for normal physiological function of all systems within the human body. Unfortunately the nervous
system has a limited capacity for self-repair and there are a plethora of disorders, diseases, and types of trauma that affect the central
and peripheral nervous systems; however, current treatment modalities are unable to remedy them. Stem cell therapy using easily
accessible mesenchymal stem cells, such as those found in the adipose stroma, has come to the fore in a number of biomedical
disciplines as a potential therapeutic regime. In addition to substantial research already having been conducted on the in vitro
differentiation of stem cells for the treatment of neurological repair, numerous strategies for the induction and culture of stem cells
into terminal neural lineages have also been developed. However, none of these strategies have yet been able to produce a fully
functional descendent suitable for use in stem cell therapy. Due to the positive effects that low level laser irradiation has shown in
stem cell studies to date, we propose that it could enhance the processes involved in the differentiation of adipose derived stem cells
into neuronal lineages.
1. Introduction
Stem cells are defined as cells that have the ability to perpetu-
ate themselves through self-renewal and to generate mature,
differentiated cells of a particular tissue. Different types of
stem cells exist, as well as the degree of their differentiation
potential or “potency.” Both the type and potency of the stem
cells are dependent on their provenance. Table 1 summarises
the different types of stem cells, their origin, and their
potency or differentiation potential. Embryonic stem cells are
pluripotent, derived from the inner cell mass of a blastocyst,
and capable of differentiating into cells of the three germ
layers (endoderm, ectoderm, and mesoderm) [1, 2].
Primordial germ cells (the precursors of gametes) have
been shown to be pluripotent and are able to be repro-
grammed into embryonic germ cells, which are also pluripo-
tent [3, 4]. Stem cells frommore differentiated tissues such as
those found in and around the developing foetus, extraem-
bryonic tissues (placenta, chorion, and umbilicus), and the
newborn infant and in older “adult” tissues are all thought to
bemultipotent.Multipotent stem cells are able to differentiate
into different cell types but usually only to cell types that are
derived from the same embryonic germ layer [5]. However,
due to the ability of some multipotent “mesenchymal” stem
cells (MSCs) derived from one germ layer to differentiate
into cells from another germ layer, it is thought that some
multipotent stem cells may in fact also be pluripotent. The
defining characteristics of MSCs are inconsistent among
investigators due, in part, to the lack of a universally accepted
surface marker phenotype. Three characteristics of MSCs
are defined and are universally accepted by most: (1) MSC
populations are plastic adherent in vitro; (2) MSCs express
antigens CD105, CD90, and CD73 and lack the expression of
hematopoietic antigens CD45, CD34, CD14, CD19, or CD3
while expressingMHCClass Imolecules in vitro but notClass
II molecules unless stimulated; (3) MSCs have the capacity to
differentiate to osteoblasts, adipocytes, and chondroblasts in
vitro [6].
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Table 1: Stem cell types, their origin, and their differentiation potential.
Origin Blastocyst Early embryo Foetus/infant Infant/adult
Stem cell type Embryonicstem cells
Primordial germ cells
Embryonic germ cells
Foetal stem cells
Foetal/maternal stem cells
Umbilical cord and placental stem cells
Adult stem cells
Induced pluripotent stem (iPS) cells
Potency Pluripotent Pluripotent MultipotentPluripotent
Multipotent
Pluripotent
References [7, 8] [3, 4] [5, 9–12] [13–17]
It is also possible to reprogramme normal “unipotent”
somatic cells into pluripotent stem cells, through the intro-
duction of four genes into the somatic cells. These cells have
been termed induced pluripotent stem cells and have many
of the same characteristics of embryonic stem cells [13, 14].
During wound healing, damaged cells are replaced with
new cells, ascendant from a stem cell niche within the
particular tissue. Most mammalian tissues have the potential
and capacity, in varying degrees, for self-repair. The nervous
system, however, has a much more limited, or indeed lacks,
capacity for this. Although neural stem cells have been
identified in the adult brain [18], their capacity and ability to
functionally replace and repair damaged or diseased tissue
in all parts of the brain and nervous system are limited
[19]. Furthermore, although neural stem cells have been
isolated and cultured from foetal and adult brain and other
central nervous tissues [20–22], the harvesting and isolation
of neural stem cells from these sources are not a practical
solution for treatment. Stem cell therapy, with the use of
mesenchymal stem cells, offers a more feasible option in
seeking a treatment modality for neuronal replacement and
repair.
2. Nervous System
Thenervous system is themaster control and communication
core of the human body. Using chemical and electrical
signals, the nervous system allows the body to react to
sensory stimuli, usually in the form of motor responses.
The nervous system is broadly divided into two principal
parts—the central nervous systemand the peripheral nervous
system. The central nervous system consists of the brain and
the spinal cord, and these decipher and translate sensory
input and in turn direct an appropriate motor response.
The peripheral nervous system is that part of the nervous
system that falls outside the central nervous system and
consists primarily of bundles of axons, that is, the nerves that
extend from the spinal cord and the brain. The peripheral
nervous system is further subdivided into the sensory and
motor divisions. Sensory nerves act as the afferent division,
transmitting impulses from the peripheral receptors to the
central nervous system. Conversely, the motor nerves act as
the efferent division conducting impulses from the central
nervous system to the effector organs, primarily the muscles
and glands. The peripheral nerves link and connect all parts
of the body to the central nervous system and act as the
communication system between the body and the brain.
3. Diseases and Trauma
Communication between the central nervous system and
the rest of the body is essential for normal physiological
functioning of the body. Neural damage, whether due to
disease, physical trauma, or degeneration, can all result in
the impairment or total loss of function of the affected
organs or systems. Neurodegeneration is most commonly
due to the aging and affects both nondividing neurons and
neural stem cells, in both the central and peripheral nervous
systems. Clinical issues resulting from neurodegeneration
include losses of memory and cognition and sensory and
motor deficits that in turn cause impairments to the func-
tioning of many individual physiological systems such as the
gastrointestinal tract (e.g., constipation), impaired vision and
hearing, and normal muscular motor function [23].
Although neurodegeneration due to age could itself be
considered a disease, there are specific diseases that affect the
nervous system to devastating consequence. These include
stroke, multiple sclerosis, spinal cord injury, and motor
neuron diseases such as amyotrophic lateral sclerosis and
spinal muscular atrophy. Spinal cord injury can be caused by
both neurodegeneration and disease, but the most common
cause is due to severe trauma to the spinal column and spinal
cord by physical means, including falls in the elderly, motor
vehicle and sporting accidents, and those brought about by
physically violent incidents [24].
4. Therapies
Treatment of neural damage is, in general, primarily pallia-
tive. This includes the prevention of the progression of the
disease/injury, management of sensory loss and spasticity,
and teaching patients how to adapt to their disabilities. Many
treatment regimens rely on drugs to attempt to improve neu-
rological function and/or support, but few have the potential
to repair and cure. These include steroids, hormones, and
opiate antagonists; however, none of these agents provide
major beneficial improvement of neurological function [25].
Due to the lack of any one or combinatory physical or
chemical therapeutic remedy available, the investigation of
cellular and molecular therapies is now at the fore of this
research. Cell therapy, in particular stem cells, is showing
promise as a potential therapy, especially in combinationwith
tissue engineering applications [26, 27].
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5. Multipotent Mesenchymal Stromal Cells
Adult stem cells are cells that possess the capacity of self-
renewal, a proliferative potential, and the ability to differ-
entiate into one or more terminal cell types [28]. Adult
stem cells, unlike embryonic stem cells, circumvent the
ethical and biological safety issues of embryonic stem cells,
such as tumorigenicity [29] and histocompatibility [30]. It
has been recommended by the International Society for
CellularTherapy that stem cells isolated from adult tissues are
designated “multipotent mesenchymal stromal cells” (MSCs)
[31]. This is due to the fact that not all adult stem cells that
are being isolated and investigated are of true embryonic
mesodermal origin. MSCs isolated from different adult tis-
sues are proving to be a valuable research tool in cell therapy.
Tissues from which MSCs have successfully been isolated
include adipose [32, 33], bone marrow [34], muscle [35],
skin [36], synovial membranes [37], and nervous tissue [38].
Most MSCs should by definition be able to be differentiated
into osteogenic, adipogenic, and chondrogenic lineages using
standard in vitro culture conditions [39].However, dependent
on the source tissue and the culture and differentiation
conditions, MSCs have also successfully been differentiated
into myogenic and neurogenic lineages [34, 40–42]. As our
understanding of MSCs expands, so do their differentiation
abilities and potential uses in tissue engineering for cell
therapy.
6. Adipose Derived Stem Cells
Autologous stem cell therapy, using adipose derived stem
cells (ADSCs), could indeed be a much more practical,
ethical, and readily accessible source of stem cells for the
use in reparative and regenerative medicine. ADSCs, like
haematopoietic stem cells (HSCs), are of mesenchymal ori-
gin; however, ADSCs are more abundant as well as being
relatively easier and more cost effective to isolate. Moreover,
the stem cell yield from adipose tissue is exponentially
higher than from bone marrow [43]. ADSCs have been
shown to be able to differentiate into adipogenic, osteogenic,
chondrogenic, myogenic, and neurogenic lineages in vitro
(Figure 1) by using cell specific culture and induction media
[32, 43, 44].
In characterising ADSCs, they phenotypically identify
as mesenchymal stem cells by expressing well documented
cluster of differentiation (CD) markers, including CD13,
CD29, CD31, CD34, CD44, CD63, CD73, CD90, and CD144
[45–49]. The expression of some of these markers has been
shown to increase and/or decrease over time, in vitro, indi-
cating an adaptive response to the culture environment [50].
Furthermore, the ability of the ADSCs to differentiate in vitro
into the lineages mentioned above is another characteristic
identification assay for their potency.
A great deal of work has been performed investigating
the differentiation of various types of stem cells, includ-
ing embryonic, induced pluripotent, and neural stem cells
into neuronal lineages for the potential use in regenerative
medicine. However, although these studies provide vital
information and a greater understanding of stem cell biology,
Embryonic stem cell
Mesodermal stem cell
Mesenchymal (adult) stem cell
Adipocyte Myoblast Fibroblast Osteoblast Chondrocyte Neurons
Figure 1: The hierarchical development of mesenchymal stem cells
and their differentiation potential into various tissue lineages.
signalling, and differentiation processes, it is questionable as
to the long term safety and efficacy of these cells for use
in regenerative treatments. Further studies into the safety of
using both embryonic and induced pluripotent stem cells are
required, as they share themajor disadvantage of being prone
to forming teratomas after transplantation in vivo [14, 51].The
use of autologous multipotent mesenchymal stromal cells,
however, potentially offers an easier, faster, and hopefully
safer option.
7. Low Intensity Laser Irradiation
Laser radiation at different intensities has been shown to
inhibit as well as stimulate cellular processes. Findings sug-
gest that, at the cellular level, laser energy of a particular
wavelength can initiate a signalling cascade that promotes
cellular proliferation [52]. Low intensity laser irradiation
(LILI), a form of phototherapy used in different clinical
conditions to promote wound healing, appears to accelerate
wound closure (i.e., the proliferation of new cells) [53]. LILI
has been shown to be of neurological benefit in studies
investigating stroke, degenerative brain disease, spinal cord
and traumatic brain injury, and peripheral nerve regeneration
as reviewed by Hashmi et al. [54]. Table 2 summarises
selected studies conducted onADSCs andneuronal stem cells
with subsequent outcomes using LILI at different parameters.
8. Neuronal Induction and Characterisation
Several protocols have been employed by researchers in
this field to induce the in vitro differentiation of ADSCs
into neural lineages. Typically, isolated ADSCs are used
and are either induced directly using chemicals and growth
factors to stimulate differentiation or coaxed into generating
neurospheres, which are then further induced using similar
chemical and growth factor containing media.
Neurosphere generation is typically induced by the addi-
tion of epidermal growth factor (EGF) and basic fibroblast
growth factor (bFGF) to the ADSC culture media [69].
However, the spontaneous formation of spheres without
4 International Journal of Photoenergy
Table 2: Laser parameters used in stem cell studies.
Study Laser parameters Results References
Human dental pulp stem
cell (hDPSC) and LILI 20mW/6 s, 40mW/3 s, 660 nm Increased viability and proliferation
[55]
ADSCS and LILI 0.153W/cm
2 for 30, 45, 60, 180, and 300 s
532 nm
Increased proliferation at 30–60 s,
longer exposure decreased proliferation, and
autofluorescence
[56]
Neuronal embryonic rat
brain cells and LILI
10, 30, 50, 110, 160, 200, and 250mW for 1, 4,
or 7min, 780 nm
Increased migration and fiber sprouting, large size
neurons with dense branched interconnected
network of neuronal fibers
[57]
Primary neuronal culture
and LILI 50mW, 0.2, 4, 10, and 30 J/cm
2, 808 nm Induced neuronal growth and neurite extension altermicroglial phenotype
[58]
Human neural progenitor
(NHNP) and LILI
50mW/cm2, 0.05 J/cm2
808 nm Increased ATP production
[59]
ADSCs and LILI 5 J/cm2, 635 nm Increased viability and proliferation [60]
ADSCs and LILI 5 J/cm2, 636 nm Increased viability and proliferation [61]
ADSCs and LILI 10 and 15 J/cm
2
830 nm Decreased viability and proliferation
[62]
ADSCs No LILI Increased viability, proliferation, and differentiation [63]
Human fibroblasts and
primary rat cortical
neurons and LILI
1W, 10mW/cm2, 0.01, 0.1, 0.5, 2, 10, 50, 200,
1,000, 5,000mJ/cm2 810 and 980 nm
Improved neurite elongation, accelerated nerve
regeneration, and improved functional recovery
[64]
ADSCs and LILI 5 J/cm2, 636 nm ADSC differentiation into smooth muscle cells [63]
ADSCs No LILI ADSC differentiation into smooth muscle cells [65]
ADSCs transplanted in
ischemic mouse limbs No LILI Enhancement of angiogenesis and osteogenesis
[66, 67]
ADSCs No Differentiation into smooth muscle cells [68]
the addition of growth factors has also been reported [70].
Dissociated neurospheres are then cultured inmedia contain-
ing a variety of differentiation factors.
Reports of experimental protocols successfully inducing
neural differentiation by the addition of factors (alone or
in combination with others) to culture media for ADSCs
or ADSC derived neurospheres include all-trans-retinoic
acid, forskolin, platelet derived growth factor (PDGF-BB),
heregulin, B27, brain derived neurotrophic factor (BDNF),
nerve growth factor (NGF), epidermal growth factor (EGF),
basic fibroblast growth factor (bFGF), ciliary neurotrophic
factor (CNTF), neurotrophin-3 (NT-3), 𝛽-mercaptoethanol
(BME), dimethyl sulfoxide (DMSO), butylated hydrox-
yanisole (BHA), insulin, indomethacin, isobutylmethylxan-
thine (IBMX), valproic acid, hydrocortisone, and azacytidine
[32, 69, 71–79].
However, the morphological and neuron-like appearance
and changes noted in chemical induction protocols, particu-
larly those using BME, DMSO, or BHA, have been reported
to be due to cell shrinkage and not neural differentiation
[80, 81]. Furthermore, the short time span in which these
changes occur in these chemical induction protocols does not
appear to be compatible with actual cellular differentiation.
It would therefore appear that neural induction via growth
factors alone or in combinationwith specific chemicals is able
to truly induce differentiation that can be determined by both
morphology and expression of neural specific markers.
Morphology alone can therefore not be an indicator of
differentiation; hence, detection of the expression of neuronal
markers is necessary. There are a plethora of neuronal mark-
ers dependent on the neuronal lineage being investigated.
These include vimentin, nestin, glial fibrillary acidic protein
(GFAP), 𝛽-tubulin III (Tuj-1), and microtubule associated
protein 2 (MAP2). Undifferentiated ADSCs have been shown
to express native immature neural proteins, such as vimentin,
GFAP, and nestin [71, 82, 83], with the expression of these
characteristic neural cell markers decreasing after neuronal
differentiation [83]. Once ADSCs are more committed along
their neural differentiation path, they express Tuj-1 and
MAP2, indicative of immature neurons [83, 84]. However,
GFAP expression has also been shown to increase after
induction of neural differentiation [82, 84]. This illustrates
the importance of understanding the expression profiles
of the different markers and their significance during the
differentiation process.
Dependent on the induction protocol and the degree
of differentiation achieved (neuronal progenitor, immature
neuron, or mature neuron), the next step in confirming
functional differentiationwould be to assess the expression of
neurotransmitter receptors and electrophysiological studies
[82, 83, 85].
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9. Influence of Laser Phototherapy on
Neuronal Differentiation of ADSCs
To date there is no data available on whether LILI can
influence the neuronal differentiation of ADSCs. However,
LILI has been shown to increase the expression of stem
cell markers in ADSCs [60] as well as the proliferation and
viability of stem cells in vitro [55, 56, 60]. Furthermore, LILI
has been successfully used to demonstrate an increase in
neuronal sprouting and migration in embryonic rat brain
cultures [57], as well as inducing neuronal growth and neurite
extension in primary neuronal and microglia cocultures
[58]. Laser irradiation has also been shown to enhance the
adenosine triphosphate (ATP) production of cultured normal
human neural progenitor cells [59]. These studies all point to
a positive effect of LILI on stem cells and neural progenitors,
unequivocally indicating that laser irradiation can indeed
play an important role in the differentiation of ADSCs into
neuronal lineages, potentially at specific or, perhaps, all stages
of the differentiation process.
10. Conclusions
It is now known that ADSCs exhibit the properties of
multipotent stem cells, and hence their role in tissue engi-
neering is invaluable. In the past decade, this relatively
new and specialised research focus of differentiating ADSCs
into neuronal lineages has progressed in leaps and bounds.
However, attaining lineage specific, terminally differentiated,
functional neurons has yet to be achieved. Results from
in vivo studies have shown that ADSCs (isolated or differ-
entiated) can promote nerve healing, but whether this is
ostensibly by direct differentiation of the transplanted cells
or via the paracrine effects of growth factors secreted by
ADSCs on the endogenous neural progenitors has yet to be
elucidated.
By understanding how neural progenitors function in
situ, we are gaining a better understanding of what it is
that we are aiming for in a terminally differentiated and
functional neuron. Not only is it a prerequisite to understand
the functional properties of the differentiated cells, but also
deciphering the regulatory pathways and mechanisms of
the ADSCs themselves will expedite the development and
usage of ADSCs for autologous stem cell therapy in treating
neurological diseases and disorders.
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